Literature DB >> 2863871

Treatment of negative symptoms.

W T Carpenter, D W Heinrichs, L D Alphs.   

Abstract

The rational treatment of the negative symptoms of schizophrenia requires a careful differentiation of those secondary to a range of other factors and those that constitute enduring primary or deficit symptoms. Secondary negative symptoms are usually responsive to treatment of the underlying cause. In contrast, there is no intervention currently available with established efficacy in treating deficit symptoms. These distinctions serve to reduce the heterogeneity of negative symptoms. A discussion of the diagnosis and treatment of the various forms of secondary negative symptoms is followed by suggestions for future research in the treatment of deficit symptoms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2863871     DOI: 10.1093/schbul/11.3.440

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  56 in total

1.  Are Negative Symptoms Dimensional or Categorical? Detection and Validation of Deficit Schizophrenia With Taxometric and Latent Variable Mixture Models.

Authors:  Anthony O Ahmed; Gregory P Strauss; Robert W Buchanan; Brian Kirkpatrick; William T Carpenter
Journal:  Schizophr Bull       Date:  2014-11-14       Impact factor: 9.306

Review 2.  Negative symptoms: psychopathological models.

Authors:  J Ananth; A Djenderdjian; P Shamasunder; J Costa; J Herrera; J Sramek
Journal:  J Psychiatry Neurosci       Date:  1991-03       Impact factor: 6.186

Review 3.  Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison.

Authors:  S R Kay
Journal:  Psychiatr Q       Date:  1990

4.  Symptom dimensions and outcome in schizophrenia.

Authors:  Raimo K R Salokangas
Journal:  World Psychiatry       Date:  2003-10       Impact factor: 49.548

5.  Schizophrenia, co-occurring substance use disorders and quality of care: the differential effect of a managed behavioral health care carve-out.

Authors:  Alisa B Busch; Richard G Frank; Anthony F Lehman; Shelly F Greenfield
Journal:  Adm Policy Ment Health       Date:  2006-05

Review 6.  Persistent negative symptoms in schizophrenia: an overview.

Authors:  Robert W Buchanan
Journal:  Schizophr Bull       Date:  2006-11-10       Impact factor: 9.306

Review 7.  Homers regulate drug-induced neuroplasticity: implications for addiction.

Authors:  Karen K Szumlinski; Alexis W Ary; Kevin D Lominac
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

8.  A few methodologic issues of note.

Authors:  William T Carpenter
Journal:  Schizophr Bull       Date:  2008-09-11       Impact factor: 9.306

Review 9.  Review: treatment of schizophrenia. State of the art.

Authors:  H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

10.  A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.

Authors:  H J Möller; H Müller; R L Borison; N R Schooler; G Chouinard
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.